Impact of Rituximab in the Clinical Outcomes of Hairy Cell Leukemia: A Single-Institution Analysis

被引：0
|
作者：
Kerr, Daniel Alan [1 ]
Gonter-Aubin, Kristen [1 ]
Rose, Ashley [2 ]
Thanh Lana Nguyen [2 ]
Ibarz, Javier Pinilla [3 ,4 ]
Chavez, Julio C. [3 ,5 ]
机构：
[1] Univ S Florida, Morsani Coll Med, Moffitt Canc Ctr, Tampa, FL USA
[2] Univ S Florida, Morsani Coll Med, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Div Malignant Hematol, Tampa, FL USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-118386
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5323
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of Rituximab in the Clinical Outcomes of Hairy Cell Leukemia: A Retrospective, Single-Institution Analysis
    Rose, Ashley
    Kerr, Daniel
    Kristen, Gonter-Aubin
    Thanh, Afiat
    Julio, Chavez
    Javier, Pinilla-Ibarz
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S284 - S285
  • [2] Impact of Rituximab in the Clinical Outcomes of Hairy Cell Leukemia: A Retrospective Single-Institution Analysis
    Gonter-Aubin, Kristen
    Kerr, Daniel Alan
    Rose, Ashley
    Thanh Lana Nguyen
    Chavez, Julio C.
    Ibarz, Javier Pinilla
    [J]. BLOOD, 2019, 134
  • [3] Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agents
    Talamo, Giampaolo
    Dolloff, Nathan G.
    Sharma, Kamal
    Zhu, Junjia
    Malysz, Jozef
    [J]. RARE TUMORS, 2012, 4 (03) : 123 - 126
  • [4] Impact of Precision Medicine on Clinical Outcomes: A Single-Institution Retrospective Study
    Quinn, Ryann
    Patel, Rajvi
    Sison, Cristina
    Singh, Amandeep
    Zhu, Xin-Hua
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series
    Rosenberg, Joshua D.
    Burian, Carol
    Waalen, Jill
    Saven, Alan
    [J]. BLOOD, 2014, 123 (02) : 177 - 183
  • [6] CLINICAL PROFILE AND TREATMENT OUTCOMES OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMA: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
    Kainickal, C. T.
    Shishak, S. A.
    Kumar, R. R.
    Rafi, M.
    Aazariah, B.
    George, P. S.
    Ramadas, K.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 60 : E8 - E8
  • [7] Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience
    Hosono, Naoko
    Ookura, Miyuki
    Araie, Hiroaki
    Morita, Mihoko
    Itoh, Kazuhiro
    Matsuda, Yasufumi
    Yamauchi, Takahiro
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (03) : 362 - 369
  • [8] Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience
    Naoko Hosono
    Miyuki Ookura
    Hiroaki Araie
    Mihoko Morita
    Kazuhiro Itoh
    Yasufumi Matsuda
    Takahiro Yamauchi
    [J]. International Journal of Hematology, 2021, 113 : 362 - 369
  • [9] Clinical outcomes of temporal bone squamous cell carcinoma: A single-institution experience
    Zheng, Yongbo
    Qiu, Ke
    Fu, Yangju
    Yang, Wenjie
    Cheng, Danni
    Rao, Yufang
    Mao, Minzi
    Song, Yao
    Xu, Wei
    Ren, Jianjun
    Zhao, Yu
    [J]. CANCER MEDICINE, 2023, 12 (05): : 5304 - 5311
  • [10] Clinical outcomes of rectal carcinnids: A single-institution experience
    Jiang, Yue
    Lu, Yufei
    Zheng, Xiaoli
    Guo, Leiming
    Chen, Xijuan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345